Section one: Contracting authority
one.1) Name and addresses
CELL AND GENE THERAPY CATAPULT
12TH FLOOR TOWER WING,GUY'S HOSPITAL, GREAT MAZE POND
LONDON
SE19RT
procurement@ct.catapult.org.uk
Country
United Kingdom
Region code
UKI44 - Lewisham and Southwark
Companies House
10016023
Internet address(es)
Main address
one.4) Type of the contracting authority
Body governed by public law
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Ribosome profiling of suspension-adapted HEK293 cells producing adeno-associated viruses
two.1.2) Main CPV code
- 73111000 - Research laboratory services
two.1.3) Type of contract
Services
two.1.4) Short description
Services for the ribosome profiling of suspension-adapted human cells producing an adeno-associated virus (AAV) vector.Human cells will be subjected to AAV production in parallel with controls. A range of samples (between 21 and 35) will be generated in this experiment, designated as "Run 1". The samples will then be processed by the awarded Bidder. In addition to "Run 1", two additional runs ("Run 2" and "Run 3") may be performed at our sole discretion. Importantly, the experimental setup for both "Run 2" and "Run 3" will be similar to that for "Run 1", but sample numbers may differ if additional conditions are included or excluded. A maximum of 35 samples will be obtained for either "Run 2" and "Run 3".
two.1.6) Information about lots
This contract is divided into lots: No
two.1.7) Total value of the procurement (excluding VAT)
Value excluding VAT: £252,000
two.2) Description
two.2.2) Additional CPV code(s)
- 73100000 - Research and experimental development services
two.2.3) Place of performance
NUTS codes
- UKI - London
two.2.4) Description of the procurement
Services for the ribosome profiling of suspension-adapted human cells producing an adeno-associated virus (AAV) vector.Human cells will be subjected to AAV production in parallel with controls. A range of samples (between 21 and 35) will be generated in this experiment, designated as "Run 1". The samples will then be processed by the awarded Bidder. In addition to "Run 1", two additional runs ("Run 2" and "Run 3") may be performed at our sole discretion. Importantly, the experimental setup for both "Run 2" and "Run 3" will be similar to that for "Run 1", but sample numbers may differ if additional conditions are included or excluded. A maximum of 35 samples will be obtained for either "Run 2" and "Run 3".
two.2.5) Award criteria
Quality criterion - Name: Quality / Weighting: 60%
Cost criterion - Name: Pricing Schedule / Weighting: 40%
two.2.11) Information about options
Options: No
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Open procedure
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: Yes
four.2) Administrative information
four.2.1) Previous publication concerning this procedure
Notice number: 2022/S 000-018191
Section five. Award of contract
A contract/lot is awarded: Yes
five.2) Award of contract
five.2.1) Date of conclusion of the contract
13 September 2022
five.2.2) Information about tenders
Number of tenders received: 2
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor
EIRNA Bio Ltd.
Cork, Ireland
Country
United Kingdom
NUTS code
- UK - United Kingdom
Companies House
604732
The contractor is an SME
Yes
five.2.4) Information on value of contract/lot (excluding VAT)
Total value of the contract/lot: £252,000
Section six. Complementary information
six.4) Procedures for review
six.4.1) Review body
Cell and Gene Therapy Catapult
London
Country
United Kingdom